Sixty patients from two centers have undergone instrumented transforaminal posterior lumbar interbody fusion (TLIF) with bioresorbable polymer cages and autograft bone for degenerative indications. This article discusses the technique of TLIF and its early outcomes. Although follow-up is short and results are preliminary, no adverse events or complications may be attributed to the bioresorbable polymer. Further multicenter clinical studies are underway with a minimum of 2 years of follow-up chosen as an endpoint to provide insight as to the future of biodegradable polymers as spinal interbody devices.